title: Novel Levofloxacin-Resistant Multidrug-Resistant Streptococcus pneumoniae Serotype 11A Isolates, South Korea.
abstract: Of 608 Streptococcus pneumoniae clinical strains isolated at a hospital in South Korea during 2009-2014, sixteen (2.6%) were identified as levofloxacin resistant. The predominant serotype was 11A (9 isolates). Two novel sequence types of multidrug-resistant S. pneumoniae with serotype 11A were identified, indicating continuous diversification of resistant strains.
authors: Miey
authors: M
authors: Park
authors: Hyun Soo
authors: HS
authors: Kim
authors: Han-Sung
authors: HS
authors: Kim
authors: Ji Young
authors: JY
authors: Park
authors: Wonkeun
authors: W
authors: Song
authors: Hyoun Chan
authors: HC
authors: Cho
authors: Jae-Seok
authors: JS
authors: Kim
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D024901:Drug Resistance, Multiple, Bacterial; D005260:Female; D006801:Humans; D064704:Levofloxacin / Q000494:pharmacology*; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D011008:Pneumococcal Infections / Q000453:epidemiology* / Q000382:microbiology*; D056910:Republic of Korea / Q000453:epidemiology; D065288:Serogroup; D013296:Streptococcus pneumoniae / Q000145:classification* / Q000187:drug effects / Q000235:genetics
chemical_list: D000900:Anti-Bacterial Agents; D064704:Levofloxacin
keywords: MDR; South Korea; Streptococcus pneumoniae; antimicrobial resistance; bacteria; levofloxacin-resistant; multidrug-resistant; respiratory infections; serotype 11A; streptococci